On September 17, 2014, the U.S. Patent and Trademark Office (USPTO) held the first Bicoastal Biotechnology, Chemical and Pharmaceutical Customer Partnership (BCBCP) Meeting. The BCBCP was created as a public forum for individuals in this industry to share ideas, experiences, and insights with the USPTO staff. During this BCBCP meeting, the USPTO indicated that they intend to release “revised” guidance on assessing patent eligible subject matter under 35 USC 101 in October 2014.
Does your new invention meet these guidelines? Is your new invention patentable subject matter? Do you have a patent pending with the USPTO and need help responding to an office action? Feel free to contact a Traverse Legal PLC patent attorney to make sure that you are informed of the most recent patent eligibility guidelines.
Stay tuned for the revised guidelines from the USPTO.